The purpose of this study was not to claim the transdermal delivery of insulin with potential therapeutic applications in diabetes but, instead, to evaluate the ability of the compounding phospholipid bases to deliver HMW drugs, such as insulin. The gene discussed is INS; the disease is diabetes mellitus.